TrialJournal of acquired immune deficiency syndromes (1999)2026

Resistance Analysis of Weekly Islatravir Plus Lenacapavir in People With HIV at 48 Weeks.

Laurie A VanderVeen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.